prof. MUDr. Luděk Pour, Ph.D.
Professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2830, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 490
2017
-
Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
LEUKEMIA & LYMPHOMA, year: 2017, volume: 58, edition: 10, DOI
-
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
Leukemia, year: 2017, volume: 31, edition: 6, DOI
-
Czech Registry of Monoclonal Gammopathies – Technical Solution, Data Collection and Visualisation
Klinická onkologie, year: 2017, volume: 30, edition: Suppl. 2, DOI
-
Deregulated expression of long non-coding RNA UCA1 in multiple myeloma
European Journal of Haematology, year: 2017, volume: 99, edition: 3, DOI
-
Diagnosis of Multiple Myeloma by Mass Spectrometry of Peripheral Blood Plasma and Artificial Intelligence
Year: 2017, type: Appeared in Conference without Proceedings
-
Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)
European Journal of Haematology, year: 2017, volume: 99, edition: 1, DOI
-
Hematologie. Pomocník ke stážím na hematologických pracovištích
Year: 2017, type:
-
Histiocytóza z indeterminovaných buněk – vymizení kožní infiltrace po ozáření elektronovým svazkem a aplikace 2-chlorodeoxyadenozinu: kazuistika
Vnitřní lékařství, year: 2017, volume: 63, edition: 4
-
IgM myeloma: A multicenter retrospective study of 134 patients
American Journal of Hematology, year: 2017, volume: 92, edition: 8, DOI
-
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
haematologica, year: 2017, volume: 102, edition: 10, DOI